Basics Xilio Therapeutics, Inc. Common Stock IPO Date: October 18, 2021 Sector: Healthcare Industry: Biotech Market Cap: $36.27M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.96% Avg Daily Range (30 D): $0.02 | 2.73% Avg Daily Range (90 D): $0.03 | 3.48% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .34M Avg Daily Volume (90 D): .85M Trade Size Avg Trade Size (Sh.): 286 Avg Trade Size (Sh.) (30 D): 389 Avg Trade Size (Sh.) (90 D): 367 Institutional Trades Total Inst.Trades: 18 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $.53M Avg Inst. Trade (90 D): $.53M Avg Inst. Trade Volume: .68M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.69M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 597.56K     News Jun 5, 2025 @ 10:38 PM Xilio Therapeutics Announces Closing of $50.0 Mill... Source: N/A Jun 2, 2025 @ 10:11 AM Xilio Therapeutics Announces Proposed Public Offer... Source: Globe Newswire May 31, 2025 @ 12:00 PM Xilio Therapeutics Announces Updated Phase 2 Data ... Source: N/A Mar 11, 2025 @ 11:30 AM Xilio Therapeutics Announces Pipeline and Business... Source: N/A Feb 10, 2025 @ 3:00 PM RNA Based Therapeutic Market Size Expected to Reac... Source: Towards Healthcare Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.16 $-.18 $-.18 Diluted EPS $-.16 $-.18 $-.18 Revenue $ 8.08M $ 2.93M $ 1.72M Gross Profit $ $ $ Net Income / Loss $ -15.84M $ -13.27M $ -13.09M Operating Income / Loss $ -14.37M $ -13.85M $ -13.63M Cost of Revenue $ $ $ Net Cash Flow $ 32.48M $ 33.79M $ -5.96M PE Ratio